the eXpand Podcast, by Respiplus – Details, episodes & analysis

In this episode, we speak with Anita Brickman, CEO of the Plasma Protein Therapeutics Association (PPTA), about the crucial and often misunderstood role of plasma-derived therapies in respiratory health. The discussion highlights how essential plasma donors are for the creation of life-saving medicines used to treat Alpha-1 Antitrypsin Deficiency (AATD) and other rare, chronic conditions. Together, we explore the rigorous global safety standards, the difference between plasma-derived therapies and traditional drugs, and the ongoing challenge of meeting the growing worldwide need for plasma donations.👇 Learn more and explore additional resources:🔹 Episode recap and resources https://chroniclungdiseases.com/en/news/understanding-patient-support-programs-in-alpha-1/🔹 Living Well with COPD – AATD Module (free) https://chroniclungdiseases.com/register🔹 Plasma Week www.plasmaweek.org 🔹 Alpha-1 www.alpha1.org🔹 PPTA Global www.PPTAGlobal.org🔹 AlphaNet Canada https://alphanetcanada.ca/🔹 Canadian Thoracic Society AATD Guidelines https://www.tandfonline.com/doi/full/10.1080/24745332.2024.2443178🔹 Learn more about Season 5 https://chroniclungdiseases.com/en/the-expand-podcast-season-5-aatd/🔹 Watch more episodes about Alpha-1 https://www.youtube.com/playlist?list=PLKERLVA6ikI5X8SabIgyphzutdp8RyKUBThis podcast is produced by RESPIPLUS™ with support from Takeda Canada to raise awareness about Alpha-1 and improve access to care across Canada.

In Episode 4 of Season 5 of the Expand Podcast, we sit down with Shanta Zurock, a clinical pharmacist and healthcare access expert, to explore the complex system challenges surrounding Alpha-1 Antitrypsin Deficiency (AATD) in Canada.Drawing from decades of experience in pharmaceutical care, Ms. Zurock offers a behind-the-scenes look at drug access, insurance navigation, and policy barriers that affect patients with rare diseases like AATD. This episode is a must-listen for healthcare professionals, advocates, and patients seeking to understand how the system works—and how to make it better.👇 Learn more and explore additional resources:🔹 Episode recap and resources https://chroniclungdiseases.com/en/news/understanding-patient-support-programs-in-alpha-1/🔹 Living Well with COPD – AATD Module (free) https://chroniclungdiseases.com/register🔹 Canadian Thoracic Society AATD Guidelines https://www.tandfonline.com/doi/full/10.1080/24745332.2024.2443178🔹 Learn more about Season 5 https://chroniclungdiseases.com/en/the-expand-podcast-season-5-aatd/🔹 Watch more episodes about Alpha-1 https://www.youtube.com/playlist?list=PLKERLVA6ikI5X8SabIgyphzutdp8RyKUBThis podcast is produced by RESPIPLUS™ with support from Takeda Canada to raise awareness about Alpha-1 and improve access to care across Canada.The eXpand Podcast episodes are available in english and french or with french subtitles available in the english version.Subscribe to The eXpand Podcast: • YouTube: https://bit.ly/eXpandPodcastYouTube• Apple Podcast: https://bit.ly/eXpandPodcastApple• Spotify: https://bit.ly/eXpandPodcastSpotify• Google Podcasts: https://bit.ly/eXpandPodcastGoogle#theexpandpodcast #alpha1 #aatdAlpha-1 antitrypsin deficiency, lung disease, patient advocacy, augmentation therapy, healthcare access, chronic obstructive pulmonary disease, genetic conditions, awareness, diagnosis, treatment

In today’s podcast we’ll talk about cardiovascular diseases, their risk factors, and their relationship with COVID-19.

Our guest is Dr. Kim Connely, a cardiologist well-known nationally and internationally for his expertise in echocardiography, cardiovascular MRI, and diabetes.

Today you’ll learn about:

• An introduction to cardiovascular diseases and risk factors
• The impact of COVID-19 on cardiovascular diseases
• The role of lifestyle modifications and prevention measures
• The importance of research in cardiovascular diseases
• The role of vaccinations in preventing complications from COVID-19

Access free resources related to this episode:

Watch more episodes related to COVID-19: https://www.youtube.com/playlist?list=PLKERLVA6ikI7Q-UToML5HBvDkq7UWOIBE

#copd #theexpandpodcast

In today's podcast episode, we're diving deep into the topic of Long COVID and its impact on respiratory health.

You’ll learn about:

• The effects of Long-COVID on respiratory health
• The groundbreaking research being conducted in this field
• The role of autoimmunity in disease severity and its connection to COVID and Long-COVID

Access free resources related to this episode: https://chroniclungdiseases.com/en/news/navigating-the-unknown-terrain-of-long-covid/

Watch more episodes related to COVID-19: https://www.youtube.com/playlist?list=PLKERLVA6ikI7Q-UToML5HBvDkq7UWOIBE

#theexpandpodcast #copd #healthcanada

Access free resources related to this episode: https://chroniclungdiseases.com/en/news/copd-techniques/

Join us for a special episode capping off the last season of the eXpand Podcast!

In this week’s episode of the eXpand Podcast, we'll explore COPD diagnosis, management, and the importance of self-management and education for patients.

We emphasized the need for more awareness and resources for patients and healthcare professionals regarding bronchiectasis.

Our guest speaker is Isabelle LeClerc, a Registered Nurse with over 35 years of experience.

Today you’ll learn about:

• The importance of understanding bronchiectasis and its symptoms.
• The importance of patient education and self-management.
• The role of airway clearance techniques in managing bronchiectasis.
• The use of devices such as the Aerobika in aiding patients with airway clearance.
• The need for a bronchiectasis registry in Canada and more resources for patients and healthcare professionals.

Stay tuned for our upcoming season of the eXpand Podcast, coming soon.

#copd #healthcanada #theexpandpodcast

Les pharmaciens jouent un rôle crucial dans la gestion des maladies respiratoires chroniques.

Mais ils sont confrontés à de nombreux défis dans la gestion de ces maladies, notamment le manque d'accès aux dossiers médicaux et les difficultés à gérer les sorties d'hôpital.

Dans l'épisode d'aujourd'hui, nous avons rencontré Marie-France Beauchesne pour discuter de la façon dont la pratique de la pharmacie évolue vers une répartition plus équilibrée entre la distribution des médicaments et les soins cliniques.

Aujourd'hui, vous apprendrez :

• Le rôle des pharmaciens dans la gestion des maladies respiratoires chroniques

• L'évolution de ce rôle et son potentiel futur pour participer plus activement aux soins des patients

• Les défis auxquels sont confrontés les pharmaciens dans la gestion de ces maladies

• L'importance de l'éducation des patients et de l'adhésion aux médicaments

Accéder à des ressources gratuites en rapport avec cet épisode : https://chroniclungdiseases.com/fr/nouvelles/vivre-plus-longtemps-avec-une-mpoc/

Abonnez-vous à The eXpand Podcast :

- YouTube : https://bit.ly/eXpandPodcastYouTube

- Apple Podcast : https://bit.ly/eXpandPodcastApple

- Spotify : https://bit.ly/eXpandPodcastSpotify

- Google Podcasts : https://bit.ly/eXpandPodcastGoogle

#theexpandpodcast #copd #healthcanada

Chronic Obstructive Pulmonary Disease (COPD) remains an underfunded and underdiagnosed health issue in the United States. It is often referred to as a "silent epidemic" due to its prevalence and the lack of awareness and resources dedicated to it.

In today’s episode of the eXpand Podcast, the discussion centers around the state of COPD care, research, and awareness, as well as the role of the COPD Foundation in driving change in the delivery of care.

Our guest is Dr. Jean Wright, CEO of the COPD Foundation.Access free resources related to this episode: https://chroniclungdiseases.com/en/news/copd-chronicles-tracing-the-journey/

Watch more episodes related to COPD: https://www.youtube.com/playlist?list=PLKERLVA6ikI5K7cWnokHO9CFyvmTCDEp2

This episode was made in collaboration with COPD Foundation.

#copd #theexpandpodcast

In the world of medical research, Chronic Obstructive Pulmonary Disease (COPD) has often been a neglected subject. Yet, recent developments have highlighted the pressing need to refocus our attention on this debilitating condition.

From addressing gender disparities in COPD research to the vital role of organizations like GOLD (Global Initiative for Chronic Obstructive Lung Disease), we'll dive into the shifting landscape of COPD studies.

Our guest is Dr. Milan Han, Professor of Medicine and Chief of the Division of Pulmonary and Critical Care at the University of Michigan.

Today you’ll learn:

• The evolving landscape of COPD research and treatment
• The importance of early diagnosis and intervention in COPD
• The impact of various risk factors beyond smoking on COPD development
• The role of cohort studies in advancing understanding of COPD

This episode was made in collaboration with GOLD.

Access free resources related to this episode: https://chroniclungdiseases.com/en/news/copd-of-all-severities

Watch more episodes related to COPD: https://www.youtube.com/playlist?list=PLKERLVA6ikI5K7cWnokHO9CFyvmTCDEp2

The eXpand Podcast episodes are available in english and french or with french subtitles available in the english version.

Subscribe to The eXpand Podcast: • YouTube: https://bit.ly/eXpandPodcastYouTube • Apple Podcast: https://bit.ly/eXpandPodcastApple • Spotify: https://bit.ly/eXpandPodcastSpotify • Google Podcasts: https://bit.ly/eXpandPodcastGoogle

#theexpandpodcast #copd #healthcanada

Dans l'épisode de cette semaine du podcast eXpand, nous allons explorer comment la réadaptation pulmonaire, la technologie et le diagnostic précoce transforment le paysage du traitement de la MPOC.

Notre invité est le Dr François Maltais, directeur de la réadaptation pulmonaire et directeur de la recherche respiratoire à l'Institut de cardiologie et de pneumologie du Québec.

Aujourd'hui, vous apprendrez

• L'efficacité et l'accessibilité de la réadaptation pulmonaire

• Le rôle de la technologie dans la démocratisation de la réadaptation pulmonaire

• L'importance d'un diagnostic précoce de la MPOC

• Le rôle et les avantages des équipes multidisciplinaires dans les soins aux patients

• La nécessité d'un soutien du système de santé pour mettre en œuvre la réadaptation pulmonaire à plus grande échelle

Accédez à des ressources gratuites en rapport avec cet épisode : https://chroniclungdiseases.com/fr/nouvelles/vivre-plus-avec-la-mpoc

In today’s podcast episode we met with Dr. Mohit Bhutani from the University of Alberta to talk about the world of COPD treatment and how it is evolving to provide better outcomes for patients.

You’ll learn about:

• The severity of COPD as a leading cause of hospitalizations and its potential for treatment improvement.
• The significance of integrating both non-pharmacological and pharmacological treatments in managing COPD effectively.
• How standardized treatment protocols have the potential to reduce mortality rates and change the landscape of COPD care.

Access free resources related to this episode: https://chroniclungdiseases.com/en/news/copd-ignored-killer/

Watch more episodes related to COPD: https://www.youtube.com/playlist?list=PLKERLVA6ikI5K7cWnokHO9CFyvmTCDEp2

#copd #theexpandpodcast